Neuren Pharmaceuticals
NEU.AX
#5633
Rank
C$1.25 B
Marketcap
$9.79
Share price
5.97%
Change (1 day)
-42.33%
Change (1 year)

Earnings for Neuren Pharmaceuticals (NEU.AX)

Earnings in 2023: C$0.19 Billion

According to Neuren Pharmaceuticals's latest financial reports the company's current earnings are C$0.15 Billion. In 2023 the company made an earning of C$0.19 Billion, an increase over its 2022 earnings that were of C$0.17 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neuren Pharmaceuticals from 2002 to 2023

Annual earnings

Year Earnings Change
2023C$0.19 B111519.63%
2022C$0.17 M-102.22%
2021-C$7.83 Million-20.06%
2020-C$9.79 Million-6.65%
2019-C$10.49 Million-449.8%
2018C$2.99 M-15.66%
2017C$3.55 M-125.7%
2016-C$13.84 Million-3.07%
2015-C$14.27 Million51.42%
2014-C$9.43 Million-32.7%
2013-C$14.01 Million87.47%
2012-C$7.47 Million10.96%
2011-C$6.74 Million-4.11%
2010-C$7.02 Million21025.61%
2009-C$0.04 Million-99.78%
2008-C$15.01 Million1.99%
2007-C$14.72 Million33.24%
2006-C$11.05 Million31.45%
2005-C$8.4 Million37.67%
2004-C$6.11 Million4.98%
2003-C$5.82 Million36.5%
2002-C$4.26 Million